STI-7349

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameSTI-7349
Drug Alias NameSTI-7349ILKN421H
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionInterleukin-2 modulators
TargetsInterleukin-2
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesThe Fourth Affiliated Hospital, Zhejiang University School Of Medcine
China Registration ClassN/A

Develop Information

Active CompaniesThe Fourth Affiliated Hospital, Zhejiang University School Of MedcineiLeukon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A